Chemotherapy Induced Nausea and Vomiting (Other Diseases) - Drugs in Development, 2021

March 2021 | 102 pages | ID: C5DD404CCFE7EN
Global Markets Direct

Abstracts

Chemotherapy Induced Nausea and Vomiting (Other Diseases) - Drugs in Development, 2021

SUMMARY

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chemotherapy Induced Nausea and Vomiting - Drugs in Development, 2021, provides an overview of the Chemotherapy Induced Nausea and Vomiting (Toxicology) pipeline landscape.

Chemotherapy induced nausea and vomiting or CINV is nausea and vomiting that results specifically from treatment with chemotherapy drugs. Symptoms include a rapid heart rate, sweating, dizziness and increased saliva. Risk factors include age, drug, dose, schedule of administration and route.

REPORT HIGHLIGHTS

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Chemotherapy Induced Nausea and Vomiting - Drugs in Development, 2021, provides comprehensive information on the therapeutics under development for Chemotherapy Induced Nausea and Vomiting (Toxicology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Chemotherapy Induced Nausea and Vomiting (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Chemotherapy Induced Nausea and Vomiting and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities/Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 3, 6, 2, 5, 1, 9, 3 and 3 respectively.

Chemotherapy Induced Nausea and Vomiting (Toxicology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content/sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

SCOPE

• The pipeline guide provides a snapshot of the global therapeutic landscape of Chemotherapy Induced Nausea and Vomiting (Toxicology).
• The pipeline guide reviews pipeline therapeutics for Chemotherapy Induced Nausea and Vomiting (Toxicology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
• The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
• The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
• The pipeline guide reviews key companies involved in Chemotherapy Induced Nausea and Vomiting (Toxicology) therapeutics and enlists all their major and minor projects.
• The pipeline guide evaluates Chemotherapy Induced Nausea and Vomiting (Toxicology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
• The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
• The pipeline guide reviews latest news related to pipeline therapeutics for Chemotherapy Induced Nausea and Vomiting (Toxicology)

REASONS TO BUY

• Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
• Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
• Find and recognize significant and varied types of therapeutics under development for Chemotherapy Induced Nausea and Vomiting (Toxicology).
• Classify potential new clients or partners in the target demographic.
• Develop tactical initiatives by understanding the focus areas of leading companies.
• Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
• Formulate corrective measures for pipeline projects by understanding Chemotherapy Induced Nausea and Vomiting (Toxicology) pipeline depth and focus of Indication therapeutics.
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
• Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Contents

Introduction
Chemotherapy Induced Nausea and Vomiting - Overview
Chemotherapy Induced Nausea and Vomiting - Therapeutics Development
Chemotherapy Induced Nausea and Vomiting - Therapeutics Assessment
Chemotherapy Induced Nausea and Vomiting - Companies Involved in Therapeutics Development
Chemotherapy Induced Nausea and Vomiting - Drug Profiles
Chemotherapy Induced Nausea and Vomiting - Dormant Projects
Chemotherapy Induced Nausea and Vomiting - Discontinued Products
Chemotherapy Induced Nausea and Vomiting - Product Development Milestones
Appendix

List Of Tables

LIST OF TABLES

Number of Products under Development for Chemotherapy Induced Nausea and Vomiting, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Companies, 2021 (Contd..1)
Products under Development by Companies, 2021
Products under Development by Companies, 2021 (Contd..1)
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Chemotherapy Induced Nausea and Vomiting - Pipeline by Acacia Pharma Ltd, 2021
Chemotherapy Induced Nausea and Vomiting - Pipeline by AcuCort AB, 2021
Chemotherapy Induced Nausea and Vomiting - Pipeline by Amzell BV, 2021
Chemotherapy Induced Nausea and Vomiting - Pipeline by Aphios Corp, 2021
Chemotherapy Induced Nausea and Vomiting - Pipeline by Athenex Inc, 2021
Chemotherapy Induced Nausea and Vomiting - Pipeline by Axim Biotechnologies Inc, 2021
Chemotherapy Induced Nausea and Vomiting - Pipeline by Benuvia Therapeutics Inc, 2021
Chemotherapy Induced Nausea and Vomiting - Pipeline by Better Life Pharmaceuticals Inc, 2021
Chemotherapy Induced Nausea and Vomiting - Pipeline by Bionorica SE, 2021
Chemotherapy Induced Nausea and Vomiting - Pipeline by Camurus AB, 2021
Chemotherapy Induced Nausea and Vomiting - Pipeline by Daewoong Pharmaceutical Co Ltd, 2021
Chemotherapy Induced Nausea and Vomiting - Pipeline by Ethicann Pharmaceuticals Inc, 2021
Chemotherapy Induced Nausea and Vomiting - Pipeline by Helsinn Group, 2021
Chemotherapy Induced Nausea and Vomiting - Pipeline by Hoverink Biotechnologies Inc, 2021
Chemotherapy Induced Nausea and Vomiting - Pipeline by IntelGenx Corp, 2021
Chemotherapy Induced Nausea and Vomiting - Pipeline by LipoSeuticals Inc, 2021
Chemotherapy Induced Nausea and Vomiting - Pipeline by LP Pharmaceutical (Xiamen) Co Ltd, 2021
Chemotherapy Induced Nausea and Vomiting - Pipeline by Luxena Pharmaceuticals Inc, 2021
Chemotherapy Induced Nausea and Vomiting - Pipeline by MannKind Corp, 2021
Chemotherapy Induced Nausea and Vomiting - Pipeline by Nevakar Inc, 2021
Chemotherapy Induced Nausea and Vomiting - Pipeline by Senzer Ltd, 2021
Chemotherapy Induced Nausea and Vomiting - Pipeline by Serina Therapeutics Inc, 2021
Chemotherapy Induced Nausea and Vomiting - Pipeline by Skye Bioscience Inc, 2021
Chemotherapy Induced Nausea and Vomiting - Pipeline by SoluBest Ltd, 2021
Chemotherapy Induced Nausea and Vomiting - Pipeline by Starton Therapeutics Inc, 2021
Chemotherapy Induced Nausea and Vomiting - Pipeline by Suda Pharmaceuticals Ltd, 2021
Chemotherapy Induced Nausea and Vomiting - Pipeline by Yichang Humanwell Pharmaceutical Co Ltd, 2021
Chemotherapy Induced Nausea and Vomiting - Dormant Projects, 2021
Chemotherapy Induced Nausea and Vomiting - Dormant Projects, 2021 (Contd..1)
Chemotherapy Induced Nausea and Vomiting - Discontinued Products, 2021

List Of Figures

LIST OF FIGURES

Number of Products under Development for Chemotherapy Induced Nausea and Vomiting, 2021
Number of Products under Development by Companies, 2021
Number of Products by Targets, 2021
Number of Products by Stage and Targets, 2021
Number of Products by Mechanism of Actions, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Top 10 Routes of Administration, 2021
Number of Products by Stage and Top 10 Routes of Administration, 2021
Number of Products by Stage and Molecule Types, 2021